Mitchell Kapoor has given his Buy rating due to a combination of factors surrounding Instil Bio’s promising therapeutic candidate, SYN-2510. Kapoor’s optimism is based on the potential market ...
Select a year and model below to get a valuation.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...